NO20043377L - R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol - Google Patents

R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol

Info

Publication number
NO20043377L
NO20043377L NO20043377A NO20043377A NO20043377L NO 20043377 L NO20043377 L NO 20043377L NO 20043377 A NO20043377 A NO 20043377A NO 20043377 A NO20043377 A NO 20043377A NO 20043377 L NO20043377 L NO 20043377L
Authority
NO
Norway
Prior art keywords
thiophen
imidazole
methoxy
ethyl
dichlorophenyl
Prior art date
Application number
NO20043377A
Other languages
English (en)
Other versions
NO327937B1 (no
Inventor
Rafael Foguet
Jorge Ramentol
Antonio Guglietta
Celia Palacin
Luis Anglada
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20043377L publication Critical patent/NO20043377L/no
Publication of NO327937B1 publication Critical patent/NO327937B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20043377A 2002-02-11 2004-08-13 R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol, fremgangsmate for fremstilling derav, preparat derav, samt anvendelse derav for behandling av soppinfeksjoner hos mennesker eller dyr, og bekjempelse av avlingssykdommer NO327937B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200328A ES2203316B1 (es) 2002-02-11 2002-02-11 R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
PCT/EP2003/001089 WO2003068770A1 (en) 2002-02-11 2003-02-04 R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE

Publications (2)

Publication Number Publication Date
NO20043377L true NO20043377L (no) 2004-08-13
NO327937B1 NO327937B1 (no) 2009-10-26

Family

ID=27675919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043377A NO327937B1 (no) 2002-02-11 2004-08-13 R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol, fremgangsmate for fremstilling derav, preparat derav, samt anvendelse derav for behandling av soppinfeksjoner hos mennesker eller dyr, og bekjempelse av avlingssykdommer

Country Status (24)

Country Link
US (1) US7323433B2 (no)
EP (1) EP1474422B1 (no)
JP (1) JP5095070B2 (no)
KR (1) KR100701457B1 (no)
CN (1) CN1315824C (no)
AT (1) ATE382618T1 (no)
AU (1) AU2003205733B8 (no)
BR (1) BR0307754A (no)
CA (1) CA2474627C (no)
CO (1) CO5601026A2 (no)
DE (1) DE60318395T2 (no)
DK (1) DK1474422T3 (no)
ES (1) ES2203316B1 (no)
IL (1) IL163452A (no)
MX (1) MXPA04007581A (no)
NO (1) NO327937B1 (no)
NZ (1) NZ534464A (no)
PL (1) PL211168B1 (no)
PT (1) PT1474422E (no)
RU (1) RU2276152C1 (no)
TN (1) TNSN04140A1 (no)
UA (1) UA78010C2 (no)
WO (1) WO2003068770A1 (no)
ZA (1) ZA200405941B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249992B1 (es) 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.
ES2249991B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
PE20110842A1 (es) * 2008-12-09 2011-11-25 Ferrer Int Polimorfo ii de un compuesto antifungico
EP2436374A1 (en) * 2010-09-30 2012-04-04 Ferrer Internacional, S.A. Ovule for vaginal administration of arasertaconazole
EP2551351A1 (en) 2011-07-29 2013-01-30 Interquim, S.A. Process for production of optically active (R)-(-)-1-(2,4-dichloro-phenyl)-2-imidazole-1-yl-ethanol
CN102440947B (zh) * 2011-11-15 2012-12-26 海南海神同洲制药有限公司 硝酸舍他康唑乳膏剂
KR101717968B1 (ko) 2016-07-18 2017-03-20 씨앤아이 주식회사 스마트폰 결합 모듈
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1475271A (en) * 1975-04-30 1977-06-01 Pfizer Ltd 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
JP3250809B2 (ja) * 1995-01-04 2002-01-28 フエルレル インターナショナル,ソシエダッド アノニマ 1−[2,4−ジクロロ−β−[(7−クロロベンゾ[b]チエニ−3−イル)メトキシ]フェネチル]イミダゾール・1硝酸塩の同質異像B及びC

Also Published As

Publication number Publication date
AU2003205733B8 (en) 2008-09-04
JP2005524639A (ja) 2005-08-18
PL370251A1 (en) 2005-05-16
US7323433B2 (en) 2008-01-29
CO5601026A2 (es) 2006-01-31
TNSN04140A1 (en) 2007-03-12
RU2276152C1 (ru) 2006-05-10
KR20040079996A (ko) 2004-09-16
ES2203316B1 (es) 2005-03-01
WO2003068770A1 (en) 2003-08-21
JP5095070B2 (ja) 2012-12-12
PT1474422E (pt) 2008-02-28
UA78010C2 (uk) 2007-02-15
AU2003205733B2 (en) 2008-08-14
ATE382618T1 (de) 2008-01-15
DE60318395D1 (de) 2008-02-14
MXPA04007581A (es) 2004-11-10
RU2004127573A (ru) 2006-02-10
US20050065201A1 (en) 2005-03-24
BR0307754A (pt) 2004-12-07
DE60318395T2 (de) 2009-01-02
CA2474627A1 (en) 2003-08-21
IL163452A (en) 2011-11-30
DK1474422T3 (da) 2008-05-13
ZA200405941B (en) 2006-07-26
ES2203316A1 (es) 2004-04-01
KR100701457B1 (ko) 2007-03-29
NZ534464A (en) 2006-02-24
CN1315824C (zh) 2007-05-16
PL211168B1 (pl) 2012-04-30
NO327937B1 (no) 2009-10-26
EP1474422A1 (en) 2004-11-10
EP1474422B1 (en) 2008-01-02
HK1070883A1 (en) 2005-06-30
CA2474627C (en) 2009-09-22
AU2003205733A1 (en) 2003-09-04
CN1630654A (zh) 2005-06-22

Similar Documents

Publication Publication Date Title
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
FR2836915B1 (fr) Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
MY125356A (en) Moxifloxacin/sodium chloride formulation
WO2004029031A3 (en) Therapeutic piperazine compounds
WO2004016086A3 (en) 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
SE9900961D0 (sv) Novel compounds
IS2613B (is) Útskipt díketópíperasín sem oxýtósínblokkar
CO5601026A2 (es) R-(-)-1-[2-(7-clorobenzo[b]tioefn-3-il-metoxi)-2- (2,4-diclorofenil)-etil]-1h-imidazol
DE69727948D1 (de) Sordarinderivate
BG104259A (bg) Производни на 4-циано-4-деформилсордарицин
BRPI0414319A (pt) agentes antibacterianos de quinolona
ATE241979T1 (de) 4-cyano-4-deformylsordarinderivate
CR7413A (es) R-(-)-1-[2-(7-Chlorobenzo[b]thiophen-3-yl-methozy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole
MXPA05013760A (es) Composicion y procedimiento de tratamiento del platanero y del bananero.
UA49382A (uk) Спосіб лікування дерматозів

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees